{"id":"W3217287927","doi":"10.1136/annrheumdis-2021-221048","title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Placebo; Psoriatic arthritis; Internal medicine; Clinical endpoint; Rheumatology; Adverse effect; Psoriasis; Arthritis; Gastroenterology; Randomized controlled trial; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004181621,0.001567706,0.002797063,0.0002974357,0.0005335952,0.001110573,0.0007737129,0.002205863,0.005929389],"category_scores_gemma":[0.00322916,0.0006510451,0.0024446,0.0003056052,0.001110578,0.001079567,0.0005002503,0.00258072,0.0009569378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004683689,"about_ca_system_score_gemma":0.0009990961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000429348,"about_ca_topic_score_gemma":0.001004569,"domain_scores_codex":[0.9983158,0.001106103,0.0001093176,0.0001579478,0.0001717423,0.0001390366],"domain_scores_gemma":[0.9977006,0.0006137806,0.000786081,0.0002269765,0.0001697482,0.0005028129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9831389,0.003646886,0.0005655377,0.0004261382,0.0005858487,0.00003169221,0.00005167494,0.000188354,0.002596155,0.00004001028,0.0006917228,0.008037037],"study_design_scores_gemma":[0.9363118,0.05891445,0.003199052,0.00003571294,0.0003245147,0.00004813041,0.00001670773,0.0002039798,0.0004155024,0.00006727305,0.0004450367,0.00001792247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878455,0.005530424,0.0005309989,0.0005873736,0.0003785437,0.0019895,0.001359692,0.0001119107,0.001666036],"genre_scores_gemma":[0.9864683,0.002519855,0.001177201,0.001025653,0.0005784154,0.003359565,0.00169159,0.00003529686,0.003144109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005929389,"threshold_uncertainty_score":0.02211481,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08340259515540617,"score_gpt":0.3537105301345444,"score_spread":0.2703079349791382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}